Abbott Laboratories

Health Care Providers / Medical Equipment / Pharmaceuticals
ABT
$ 113 0.71
Share price
$ 198 bn
Market Cap
$ 207 bn
Enterprise Value

Carbon footprint

4.4 Ton
GHG emissions per $ 1 mln investment
0.15x the weighted average for S&P 500
FY2020
How is this calculated?
-5.8%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-2.4%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Abbott Laboratories aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2018


This target has not been verified as science based according to SBTi
Abbott Laboratories's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Abbott Laboratories's GHG emissions (market-based) (Kt of CO2e)
Abbott Laboratories's Carbon intensity (Tons per 1 USDm)

Abbott Laboratories's carbon footprint

Abbott Laboratories reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 906 Kt (-56 /-5.8% y-o-y). Also positively, carbon intensity decreased to 26 t (-4 /-13.2% y-o-y).

No public disclosure of Scope 3 emissions has been found for Abbott Laboratories at the moment.

The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2018, which translates into the estimated reduction of -22 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...